Development of Thrombosomes, a Lyophilized Human Platlet Derivative Therapeutic

Award Notice Posted

Solicitation number
BAA-12-100-SOL-00011
Agency
Awarded
to Polynovo Biomaterials PTY LTD
Set-aside
No set-aside

Opportunity facts

Contract number
HHSO201300021C Federal contract award
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
Not on record

Notice details come from SAM.gov. Updated .

Notice text

The purpose of this announcement is for the award of a cost plus fixed fee type contract to CELLPHIRE, INC., for the development of Thrombosomes®, a Lyophilized Human Platlet Derivative Therapeutic. This award includes funding for the base period of performance. The subject contract also contains three (3) options to extend the term of the contract.

Notice history

Notice Type Posted
Research and Development of Biodegradable Temporizing Matrix BTM Latest Award Notice
This notice Original Award Notice

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity